As of 2025-12-20, the EV/EBITDA ratio of Harpoon Therapeutics Inc (HARP) is -18.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HARP's latest enterprise value is 483.51 mil USD. HARP's TTM EBITDA according to its financial statements is -26.68 mil USD. Dividing these 2 quantities gives us the above HARP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 15.1x | 13.9x |
| Forward P/E multiples | 15.8x - 21.9x | 18.8x |
| Fair Price | (19.28) - (18.41) | (20.00) |
| Upside | -183.8% - -180.0% | -186.9% |
| Date | EV/EBITDA |